Table of Content

Table of Contents

Global Prescription Dermatological Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Prescription Dermatological Drugs Market by Value
2.2.1 Global Prescription Dermatological Drugs Revenue by Type
2.2.2 Global Prescription Dermatological Drugs Market by Value (%)
2.3 Global Prescription Dermatological Drugs Market by Production
2.3.1 Global Prescription Dermatological Drugs Production by Type
2.3.2 Global Prescription Dermatological Drugs Market by Production (%)

3. The Major Driver of Prescription Dermatological Drugs Industry
3.1 Historical & Forecast Global Prescription Dermatological Drugs Demand
3.2 Largest Application for Prescription Dermatological Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Prescription Dermatological Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Prescription Dermatological Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Prescription Dermatological Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Prescription Dermatological Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Prescription Dermatological Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Prescription Dermatological Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Prescription Dermatological Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Prescription Dermatological Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Prescription Dermatological Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Prescription Dermatological Drugs Average Price Trend
12.1 Market Price for Each Type of Prescription Dermatological Drugs in US (2018-2022)
12.2 Market Price for Each Type of Prescription Dermatological Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Prescription Dermatological Drugs in China (2018-2022)
12.4 Market Price for Each Type of Prescription Dermatological Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Prescription Dermatological Drugs in India (2018-2022)
12.6 Market Price for Each Type of Prescription Dermatological Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Prescription Dermatological Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Prescription Dermatological Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Prescription Dermatological Drugs

14. Prescription Dermatological Drugs Competitive Landscape
14.1 Johnson & Johnson
14.1.1 Johnson & Johnson Company Profiles
14.1.2 Johnson & Johnson Product Introduction
14.1.3 Johnson & Johnson Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck
14.2.1 Merck Company Profiles
14.2.2 Merck Product Introduction
14.2.3 Merck Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bayer
14.3.1 Bayer Company Profiles
14.3.2 Bayer Product Introduction
14.3.3 Bayer Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Mylan Pharmaceuticals
14.4.1 Mylan Pharmaceuticals Company Profiles
14.4.2 Mylan Pharmaceuticals Product Introduction
14.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Pfizer
14.5.1 Pfizer Company Profiles
14.5.2 Pfizer Product Introduction
14.5.3 Pfizer Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 F. Hoffmann-La Roche
14.6.1 F. Hoffmann-La Roche Company Profiles
14.6.2 F. Hoffmann-La Roche Product Introduction
14.6.3 F. Hoffmann-La Roche Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Allergan
14.7.1 Allergan Company Profiles
14.7.2 Allergan Product Introduction
14.7.3 Allergan Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Valeant Pharmaceuticals
14.8.1 Valeant Pharmaceuticals Company Profiles
14.8.2 Valeant Pharmaceuticals Product Introduction
14.8.3 Valeant Pharmaceuticals Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 PharmaDerm Pharmaceuticals
14.9.1 PharmaDerm Pharmaceuticals Company Profiles
14.9.2 PharmaDerm Pharmaceuticals Product Introduction
14.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Allergan Inamed Corporation
14.10.1 Allergan Inamed Corporation Company Profiles
14.10.2 Allergan Inamed Corporation Product Introduction
14.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Prescription Dermatological Drugs Industry (Volume)
Figure 2. Prescription Dermatological Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Prescription Dermatological Drugs Revenue in 2022
Figure 5. US Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Prescription Dermatological Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Prescription Dermatological Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Prescription Dermatological Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Prescription Dermatological Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Prescription Dermatological Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Prescription Dermatological Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Prescription Dermatological Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Prescription Dermatological Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Johnson & Johnson Profiles
Table 61. Johnson & Johnson Prescription Dermatological Drugs Product Introduction
Table 62. Johnson & Johnson Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Johnson & Johnson Strategic initiatives
Table 64. Merck Profiles
Table 65. Merck Prescription Dermatological Drugs Product Introduction
Table 66. Merck Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck Strategic initiatives
Table 68. Bayer Profiles
Table 69. Bayer Prescription Dermatological Drugs Product Introduction
Table 70. Bayer Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bayer Strategic initiatives
Table 72. Mylan Pharmaceuticals Profiles
Table 73. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Introduction
Table 74. Mylan Pharmaceuticals Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Mylan Pharmaceuticals Strategic initiatives
Table 76. Pfizer Profiles
Table 77. Pfizer Prescription Dermatological Drugs Product Introduction
Table 78. Pfizer Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Pfizer Strategic initiatives
Table 80. F. Hoffmann-La Roche Profiles
Table 81. F. Hoffmann-La Roche Prescription Dermatological Drugs Product Introduction
Table 82. F. Hoffmann-La Roche Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. F. Hoffmann-La Roche Strategic initiatives
Table 84. Allergan Profiles
Table 85. Allergan Prescription Dermatological Drugs Product Introduction
Table 86. Allergan Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Allergan Strategic initiatives
Table 88. Valeant Pharmaceuticals Profiles
Table 89. Valeant Pharmaceuticals Prescription Dermatological Drugs Product Introduction
Table 90. Valeant Pharmaceuticals Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Valeant Pharmaceuticals Strategic initiatives
Table 92. PharmaDerm Pharmaceuticals Profiles
Table 93. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Introduction
Table 94. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. PharmaDerm Pharmaceuticals Strategic initiatives
Table 97. Allergan Inamed Corporation Profiles
Table 98. Allergan Inamed Corporation Prescription Dermatological Drugs Product Introduction
Table 99. Allergan Inamed Corporation Prescription Dermatological Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Allergan Inamed Corporation Strategic initiatives